This month, we are headed to FDA on the 22nd for Sarepta's Advisory Committee. This is a historic moment for Duchenne and the opportunity to make our voices heard. There is an unprecedented collaboration of organizations and academic institutions working together to #makeduchennehistory.
We are waiting for the FDA to say yes. Like these kids:
READ THE TESTIMONIES, they are amazing. More are coming in all the time. We will continue to post but this is an incredible display of the strength of the Duchenne community and the need for treatments.
This is going to be an unprecedented meeting with over 300 patients and families registered and the number is growing. We have over 40 global organizations, foundations and academic institutions collaborating on a letter to FDA urging for the approval of eteplirsen.
We are standing on the precipice of what we have been fighting for since 2001. We are changing the paradigm of how drugs are approved and making the patient perspective count. And this is about more than just Duchenne, it's about changing the model for how drugs are approved for all rare diseases.
Thank you to all who support and donate to the Jett Foundation because we are achieving our goals and making the future better for all affected by Duchenne.
We need to continue and there is still much work to be done. We need more programs, more camp, more advocacy. We have great things on the radar screen for 2016 and we need your support and participation.
Donate! We need your support to get treatments to all affected by Duchenne and to support the programs to make lives better. And if you want to help a family get to Sarepta's Advisory Committee, go here. Thank you for being dedicated to ending Duchenne.
Best, 
Christine McSherry, Jett's Mom
Executive Director, Jett Foundation
|